Morihito Okada Selected Research

Morihito Okada Research Topics

Disease

108	Neoplasms (Cancer) 11/2022 - 08/2003
70	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2022 - 07/2004
55	Lung Neoplasms (Lung Cancer) 01/2022 - 09/2004
35	Breast Neoplasms (Breast Cancer) 05/2022 - 03/2009
32	Adenocarcinoma of Lung 11/2022 - 09/2003
30	Esophageal Squamous Cell Carcinoma 07/2022 - 08/2014
25	Esophageal Neoplasms (Esophageal Cancer) 05/2022 - 09/2008
20	Adenocarcinoma 11/2022 - 12/2003
17	Neoplasm Metastasis (Metastasis) 07/2022 - 03/2009
17	Malignant Mesothelioma 01/2022 - 03/2007
15	Lymphatic Metastasis 11/2022 - 12/2012
11	Squamous Cell Carcinoma (Epidermoid Carcinoma) 02/2021 - 03/2006
10	Mesothelioma 01/2022 - 03/2007
8	Stomach Neoplasms (Stomach Cancer) 04/2015 - 12/2008
7	Triple Negative Breast Neoplasms 05/2022 - 11/2011
7	Disease Progression 01/2022 - 05/2012
7	Interstitial Lung Diseases (Interstitial Lung Disease) 12/2021 - 09/2012
6	Fistula 01/2022 - 04/2011
6	Carcinoma (Carcinomatosis) 02/2017 - 03/2007
5	Margins of Excision 01/2021 - 01/2018
3	Vomiting 10/2022 - 06/2019
3	Nausea 10/2022 - 06/2019
3	Lung Injury 01/2022 - 12/2002
3	Febrile Neutropenia 07/2021 - 06/2012
3	Pneumonia (Pneumonitis) 06/2021 - 03/2015
3	Bronchial Fistula 02/2021 - 11/2012
3	Anorexia 12/2020 - 06/2019
3	Hemorrhage 06/2019 - 03/2007
3	Carcinogenesis 01/2019 - 05/2011
3	Pathologic Complete Response 03/2018 - 07/2012
3	Hyperplasia 03/2018 - 01/2005
3	Inflammation (Inflammations) 01/2017 - 12/2002
3	Hypoxia (Hypoxemia) 12/2015 - 06/2004
3	Colorectal Neoplasms (Colorectal Cancer) 11/2014 - 11/2008
2	Emphysema 07/2021 - 03/2014
2	Fibrosis (Cirrhosis) 06/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

18	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 03/2009
16	Biological ProductsIBA 05/2021 - 09/2003
15	Biomarkers (Surrogate Marker)IBA 07/2022 - 09/2003
13	Carcinoembryonic AntigenIBA 03/2019 - 08/2003
12	Fluorouracil (Carac)FDA LinkGeneric 08/2019 - 12/2008
11	ErbB Receptors (EGF Receptor)IBA 11/2022 - 08/2010
11	Deoxyglucose (2 Deoxy D glucose)IBA 01/2022 - 07/2011
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 10/2011
9	Docetaxel (Taxotere)FDA Link 07/2021 - 12/2008
8	NivolumabIBA 01/2022 - 09/2019
7	Pemetrexed (MTA)FDA Link 01/2022 - 03/2009
7	Paclitaxel (Taxol)FDA LinkGeneric 09/2021 - 06/2008
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 04/2016
6	Bevacizumab (Avastin)FDA Link 01/2022 - 04/2016
6	Estrogen ReceptorsIBA 09/2021 - 10/2011
6	Phenobarbital (Luminal)FDA Link 09/2021 - 02/2015
5	Pharmaceutical PreparationsIBA 11/2021 - 03/2013
5	Calbindin 2IBA 01/2020 - 03/2007
5	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 03/2006
4	Immune Checkpoint InhibitorsIBA 01/2022 - 09/2019
4	PlatinumIBA 01/2022 - 06/2015
4	Monoclonal AntibodiesIBA 01/2022 - 01/2012
4	Cyclophosphamide (Cytoxan)FDA LinkGeneric 09/2021 - 06/2009
4	human ERBB2 proteinIBA 09/2021 - 09/2013
4	Claudin-4IBA 03/2019 - 01/2017
4	Carboplatin (JM8)FDA LinkGeneric 10/2018 - 06/2008
3	AlbuminsIBA 10/2022 - 01/2018
3	Estrogens (Estrogen)FDA Link 09/2021 - 09/2013
3	taxaneIBA 09/2021 - 04/2015
3	Trastuzumab (Herceptin)FDA Link 07/2021 - 11/2011
3	LigandsIBA 03/2021 - 01/2020
3	RNA (Ribonucleic Acid)IBA 06/2020 - 03/2009
3	Hormones (Hormone)IBA 06/2019 - 10/2013
3	Messenger RNA (mRNA)IBA 08/2017 - 03/2006
3	AntigensIBA 01/2017 - 09/2003
3	Indicators and Reagents (Reagents)IBA 01/2016 - 09/2004
3	Cell Adhesion Molecule-1IBA 08/2015 - 09/2003
3	Orotate PhosphoribosyltransferaseIBA 12/2008 - 09/2008
2	C-Reactive ProteinIBA 10/2022 - 01/2017
2	fosaprepitant FDA Link 10/2022 - 06/2022
2	Erlotinib Hydrochloride (CP 358,774)FDA Link 01/2022 - 01/2019
2	Vinorelbine (Navelbine)FDA LinkGeneric 01/2022 - 01/2021
2	Gefitinib (Iressa)FDA Link 01/2022 - 04/2016
2	cremophorIBA 09/2021 - 04/2015
2	Albumin-Bound Paclitaxel FDA Link 09/2021 - 04/2015
2	B7-H1 AntigenIBA 03/2021 - 01/2020

Therapy/Procedure

53	Segmental Mastectomy (Lumpectomy) 11/2022 - 09/2004
38	Therapeutics 03/2022 - 06/2008
29	Neoadjuvant Therapy 05/2022 - 03/2011
25	Drug Therapy (Chemotherapy) 10/2022 - 09/2008
21	Lymph Node Excision (Lymph Node Dissection) 01/2022 - 03/2006
19	Esophagectomy 05/2022 - 05/2009
16	Adjuvant Chemotherapy 11/2022 - 09/2013
14	Chemoradiotherapy 05/2022 - 03/2011
14	Operative Surgical Procedures 10/2021 - 01/2005
10	Radiotherapy 01/2022 - 06/2016
10	Pneumonectomy (Lung Volume Reduction) 02/2021 - 03/2007
5	Induction Chemotherapy 01/2022 - 03/2009
3	Immunotherapy 11/2021 - 01/2021
3	Gastrectomy 01/2020 - 02/2010
3	Aftercare (After-Treatment) 01/2019 - 09/2012
3	Stents 01/2019 - 04/2011
3	Thoracotomy 01/2017 - 03/2011
3	Operative Time 06/2016 - 03/2007